MRNA Competitors & Alternatives

Compare Moderna, Inc. Common Stock with similar stocks in the same industry

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

MRNA

Main Stock
$47.84
Tradestie Score
53
Market Cap
$10.74B
Revenue Growth
-0.3%
Analyst Upside
-8.5%

Top Competitors

170 stocks in BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Company Price Market Cap P/E Score Action
AMGN Amgen Inc
$350.23
$160.70B 24.8 58 Compare
GILD Gilead Sciences Inc
$136.36
$137.92B 20.2 56 Compare
ARGX argenx SE American Depositary Shares
$704.26
$46.96B 35.4 61 Compare
BNTX BioNTech SE American Depositary Share
$85.28
$24.57B - 48 Compare
BIIB Biogen Inc. Common Stock
$187.19
$22.61B 21.7 64 Compare
NBIX Neurocrine Biosciences Inc
$129.22
$13.59B 28.3 63 Compare
EXEL Exelixis Inc
$41.90
$11.09B 15.4 62 Compare
QGEN QIAGEN N.V.
$39.10
$10.04B 19.5 54 Compare
TECH Bio-Techne Corp.
$51.79
$9.33B 99.4 55 Compare
HALO Halozyme Therapeutics, Inc.
$61.72
$8.77B 24.7 61 Compare

Data updated: Mar 30, 2026 | Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) (SIC 2836)

170 stocks in this industry